1-3 of 3
Philip Stephens
Close
Sort by
Journal Articles

Novel Genomic Alterations in MCL1 and ARID1A Identified in Pediatric Burkitt Lymphoma Using Targeted High-Throughput Sequencing

Lisa Giulino Roth, MD, Kai Wang, PhD, Theresa MacDonald, Susan Mathew, PhD, YiFang Tam, MD, Maureen T Cronin, PhD, Gary Palmer, MD, JD, MBA, MPH, Norma Lucena-Silva, PhD, Francisco Pedrosa, MD, Marcia Pedrosa, MD, Julie Teruya-Feldstein, MD, Govind Bhagat, MBBS, Bachir Alobeid, MD, Lorenzo Leoncini, MD, Cristiana Bellan, MD, Emily Rogena, Mark A Rubin, MD, Raul Ribeiro, MD, Roman Yelensky, PhD, Wayne Tam, MD, PhD, Philip Stephens, PhD, Ethel Cesarman, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 899.
https://doi.org/10.1182/blood.V120.21.899.899
Published: 2012
Journal Articles

The V617F JAK2 Mutation Is Uncommon in Cancers and Mutations in STAT5A, STAT5B and the JAK Family Genes Do Not Account for V617F Negative Myeloproliferative Disorders.

Joanna E. Baxter, Linda M. Scott, Peter J. Campbell, Tony Todd, Philip Stephens, Sarah Edkins, Richard Wooster, Michael R. Stratton, Andrew P. Futreal, Anthony R. Green
Journal: Blood
Blood (2005) 106 (11): 2598.
https://doi.org/10.1182/blood.V106.11.2598.2598
Published: 2005
Journal Articles

The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders

Linda M. Scott, Peter J. Campbell, E. Joanna Baxter, Tony Todd, Philip Stephens, Sarah Edkins, Richard Wooster, Michael R. Stratton, P. Andrew Futreal, Anthony R. Green
Journal: Blood
Blood (2005) 106 (8): 2920–2921.
https://doi.org/10.1182/blood-2005-05-2087
Published: 2005